Final-Program-ATS-2023-AP.vp

250

TUESDAY • MAY 23

P201 Did the Omicron Variant Bring a New Wave of Pneumothorax and Pneumomediastinum in COVID-19?/ F. Aldaghlawi, Cleveland, OH P202 Is Elevated HbA1c Directly Proportional to COVID-19 Mortality?/ F. Badar, Port Jefferson, NY P203 Obesity: Risk Factor for High Morbidity and Mortality in COVID-19: A Single Institute Analysis/ F. Badar, Port Jefferson, NY P204 ACEI, ARB and Diuretic Usage: Implications on Survival in Patients With COVID-19 Admitted to Mather Hospital/ F. Badar, Port Jefferson, NY P205 High Flow Nasal Cannula in Hypoxemic Patients With COVID-19 in Philippine Heart Center: A Cross-sectional Study/ K. Sy, Quezon, Philippines P206 Transaminiases and Their Association With Disease Severity and Mortality in Patients With Corona Virus Disease 2019 (COVID-19) in a Tertiary Hospital in the Philippines/ J.R. Camaquin, Batac City, Philippines P207 Undiagnosed Obstructive Sleep Apnoea as a Risk Factor for Requiring Critical Care Admission Due to COVID-19/ S.J. Patel, Warrington, United Kingdom P208 COVID-19-Related Hospitalization and Severe Outcomes Among Native Hawaiians and Pacific Islanders/ C. Nicholas, Honolulu, HI P209 Clinical Features of Pneumothorax, Pneumomediastinum, and Subcutaneous Emphysema in Hospitalized COVID-19 Patients/ J.E. Sinclair De Frias, Jacksonville, FL P210 Mechanical Power Components in COVID-19-induced Acute Respiratory Distress Syndrome/ E.R. Enric, Barcelona, Spain P211 Maternal and Fetal Outcomes in Pregnant Women With Severe SARS-CoV-2 Infection/ J.M. Habibullah, New Hyde Park, NY P212 Clinical Outcomes of New Onset Hyperglycemia in Non-diabetic Patients With COVID-19 Infection/ H. Shanmugavel Geetha, Worcester, MA P213 Fungemia as Cause of Death in Patients With COVID-19 Pneumonia Hospitalized in the Intensive Care Unit/ A.L. Chai, Los Angeles, CA P214 Comparative Study of Clinical Outcomes of Severe and Critical COVID 19 Patients Who Underwent and Did Not

P187 Analysis of Memory T-cell Subsets and Their Mitochondrial Status to SARS-CoV2 Spike Peptide Activation in COVID-19 Patient PBMC Samples/ S. Alagesan, Galway, Ireland P188 Quantitative Pulmonary Perfusion in Patients With COVID-19 by Using Dynamic Contrast Enhanced MRI at 0.55T/ A.E. Campbell-Washburn, Bethesda, MD P189 Effectiveness of Awake Self-Proning in Improving Oxygen Saturation in Patients With Acute Hypoxic Respiratory Failure Related to COVID-19 Pneumonia/ G.J. Hernandez Romero, Bronx, NY P190 The Kinetics of Blood-soluble Mediators in Hospitalized COVID-19 Patients Infected With the Omicron Variant Compared to the Alpha Variant/ L. Appleton, Chapel Hill, NC P191 ICU-19 Score as a Simplified Predictive Scoring Model for Intensive Care Unit Admissions in Patients With COVID-19/ A. Atasi, Southfield, MI P192 Differences in Health Care Outcomes Among Patients Diagnosed With COVID-19 Infection in 2020 Between Teaching and Non-teaching Hospitals- Nationwide Cohort Study/ M. Nguyen, Las Vegas, NV P193 Drivers of Mortality in COVID ARDS Depend on Patient Sub-type/ N. Hajizadeh, Madrid, Spain P194 Hyperglycemia on Admission Is Associated With Worse Outcomes and Severity of Illness in Critically Ill COVID-19 Patients/ J.S. Gonzalez-Lopez, San Luis Potosi, Mexico P195 Patients On and Off Metformin and Implications on Survival in Patients With COVID-19 Admitted to Mather Hospital/ C. Gearges, Port Jefferson, NY P196 Echocardiogram Characteristics and Outcome in Patients With COVID 19 Infection Admitted to ICU/ C. Gearges, Port Jefferson, NY P197 Impact of Antimicrobial Use at the Start of Mechanical Ventilation on Ventilator-associated Lower Respiratory Tract Infections in Patients With Acute Respiratory Distress Syndrome Related to Coronavirus Disease 2019/ J. Ishii, Hiroshima, Japan P198 Validation of the Modified ROX Index Incorporating Heart Rate in COVID 19 Patients on High Flow Nasal Cannula/ R. Rojo, Manila, Philippines P199 Effect on Glycemic Control in COVID-19 Patients in Multiple Community Hospital Intensive Care Units/ S. Choudhury, Corpus Christi, TX P200 Bacterial Pneumonia in COVID-19: Do We Have a Diagnostic Tool?/ A. Saha, Worcester, MA

Undergo Hemoperfusion Admitted in a Referral Hospital/ M.W. Tibubos, Quezon City, Philippines

ATS 2023 • Washington, DC